D3-büyüme hormon reseptör polimorfizminin akromegali hastalarında klinik, metabolik ve kardiyovasküler etkileri
The clinical and cardiometabolic effects of D3 growth hormone receptor polymorphism in acromegaly
- Tez No: 339470
- Danışmanlar: PROF. DR. TOMRİS ERBAŞ
- Tez Türü: Tıpta Yan Dal Uzmanlık
- Konular: Endokrinoloji ve Metabolizma Hastalıkları, Endocrinology and Metabolic Diseases
- Anahtar Kelimeler: Akromegali, Büyüme hormonu, Diabetes mellitus-tip 2, Koroner hastalık, Neoplazmlar, Polimorfizm-genetik, İnsülin benzeri büyüme faktörü I, Acromegaly, Growth hormone, Diabetes mellitus-type 2, Coronary disease, Neoplasms, Polymorphism-genetic, Insulin like growth factor I
- Yıl: 2013
- Dil: Türkçe
- Üniversite: Hacettepe Üniversitesi
- Enstitü: Tıp Fakültesi
- Ana Bilim Dalı: Endokrinoloji ve Metabolizma Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
Amaç: Büyüme hormon reseptör (GHR) geninin sık görülen polimorfik varyantlarından birisi ekzon 3 içeren
Özet (Çeviri)
Background and aim: A common polymorphic variant of the growth hormone receptor (GHR) consists of genomic deletion of exon 3 (d3GHR) or full-length genotype (flGHR). D3GHR is associated with increased responsiveness to signal transduction of the exogenous GH. The aim of this study was to determine the relationship between the d3GHR polymorphism and clinical parameters and comorbidities of the acromegalic patients. Methods: 118 acromegalic patients (61F/57M, age: 50.3±12.2 yrs) and 108 healthy controls (94F/ 14M, age: 41.1±11.1 yrs) were included in the study. Genotype analysis was performed by PCR. The prevalence of d3GHR polymorphism was compared in patients and controls. Demographic features, comorbidities of the patients, GH, IGF-1 levels at diagnosis, features of the adenoma and treatment modalities were evaluated. Results: Seventy-one patients (60.2%) were fl/flGHR, 40 patients (33.9%) were heterozygotes (fl/d3GHR) and 7 patients (5.9%) were homozygotes (d3/d3GHR) for genomic deletion of exon 3. The prevalence of fl/fl GHR, fl/d3GHR and d3/d3GHR in controls were 57.4%, 29.6% and 13% respectively. No significant difference was observed in the distribution of these polymorphisms among the groups. Heterozygotes and homozygotes for the d3 allele were considered together (d3GHR) in the patients and compared with fl/flGHR group. D3GHR and fl/flGHR patients showed similar anthropometric measures. Baseline GH and IGF-1 levels did not differ between the groups. A significant correlation between GH and IGF-1 levels (r:0.498, p<0.001) was observed in fl/flGHR group whereas no significant association was found in d3GHR group (r:0.283, p=0.08). Both groups showed similar adenoma features (size and the presence of cavernous sinus invasion). The prevalence of comorbidities such as coronary artery disease, hypertension, hyperlipidemia, diabetes mellitus and multinodular guatr were similar in both groups. There were 23 cancer patients (19.5%) and there was no significant difference in the prevalence of cancer among d3GHR and fl/flGHR patients (n:6, 12.8% vs n:17, 23.9%, respectively). The prevalence of renal cortical cyst and nefrolithiasis were also equally distributed. Moreover, treatment modalities did not show any difference. Conclusion: The distribution of the genotype for d3GHR in this study was similar to previous studies in acromegaly. Controversial results have been reported in studies about the effect of D3GHR polymorphism in acromegaly that more favourable metabolic phenotype was found in d3GHR patients in a study while significantly higher BMI and HOMA-IR values were observed in d3/d3GHR group in another study. Our study supports that the genotype of d3GHR variant seems to have no impact on clinical features and comorbidities of acromegalic patients, but may play role in the GH/IGF-1 disassociation in acromegaly.
Benzer Tezler
- Yeni tanı almış meme kanserli hastalarda tirodi fonksiyon bozukluğu ve d vitamini eksikliği sıklığının araştırılması
Investigation of the prevalence of thyroid dysfunction, autoimmune thyroid disease and vitamin d deficiency in newly diagnosed breast cancer patients
DURMUŞ AYAN
Tıpta Uzmanlık
Türkçe
2016
Endokrinoloji ve Metabolizma HastalıklarıSağlık Bilimleri ÜniversitesiTıbbi Biyokimya Ana Bilim Dalı
DOÇ. DR. ERDİNÇ SERİN
- Mobil telefon kullanımına bağlı oluşan 900-1800 mhz radyo frekans dalgalarının meydana getirdiği elektromanyetik alanın iliak kanat kemik mineral yoğunluğuna etkisi
The effect of electromagnetic fields on bone mineral density of iliac bone produced by 900-1800 mhz radio frequency waves dependent on cellular phone usage
BEŞİR ANDAÇ AKSOY
Tıpta Uzmanlık
Türkçe
2006
Ortopedi ve TravmatolojiSüleyman Demirel ÜniversitesiOrtopedi ve Travmatoloji Ana Bilim Dalı
PROF.DR. NEVRES HÜRRİYET AYDOĞAN
- Üremik sıçan derisinde FGF23 ekspresyonun ve FGFR1'in histopatolojik değişimlerinin belirlenmesi ve mineral konsantrasyonu ile ilişkileri
Determination of FGF23 expression and histopathological changes of FGFR1 in uremic rat skin and relationship with mineral concentration
ÖZGE ÖZKAYNAK
Yüksek Lisans
Türkçe
2019
FizyolojiSivas Cumhuriyet ÜniversitesiFizyoloji Ana Bilim Dalı
DOÇ. DR. SEMA TULAY KÖZ
- Bağırsak hasar modellerinde kemik iliği mezenkimal kök hücre ve bağırsak mezenkimal kök hücrelerin rejeneratif ve immün modülatuvar etkilerinin karşılaştırılması
Comparison of regenerative and immune modulatory effecets of bone marrow and intestinal mesenchymal stem cells i intestinal damage models
BURCU PERVİN
Doktora
İngilizce
2025
BiyolojiHacettepe ÜniversitesiKök Hücre Ana Bilim Dalı
DOÇ. DR. FATİMA AERTS KAYA
- Deneysel mide ülserinde ghrelinin koruyucu ve tedavi edici etkisini göstermek
The investigation of protective and therapeutic effect of ghrelin in experimental gastric ulcer
EZEL TAŞDEMİR
Tıpta Uzmanlık
Türkçe
2004
GastroenterolojiDicle Üniversitesiİç Hastalıkları Ana Bilim Dalı
PROF. DR. FİKRİ CANORUÇ